Dr. David Conen, MD, MPH
Claim this profileStudies Stroke
Studies Atrial Fibrillation
1 reported clinical trial
4 drugs studied
Clinical Trials David Conen, MD, MPH is currently running
More about David Conen, MD, MPH
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments David Conen, MD, MPH has experience with
- Edoxaban
- Apixaban
- Dabigatran
- Rivaroxaban
Breakdown of trials David Conen, MD, MPH has run
Atrial Fibrillation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Conen, MD, MPH specialize in?
David Conen, MD, MPH focuses on Stroke and Atrial Fibrillation. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is David Conen, MD, MPH currently recruiting for clinical trials?
Yes, David Conen, MD, MPH is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that David Conen, MD, MPH has studied deeply?
Yes, David Conen, MD, MPH has studied treatments such as Edoxaban, Apixaban, Dabigatran.
What is the best way to schedule an appointment with David Conen, MD, MPH?
Apply for one of the trials that David Conen, MD, MPH is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.